Management of respiratory syncytial virus infections in the immunocompromised child.
Moscona
A
A
Mt. Sinai School of Medicine, New York, NY, USA.
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D018357:Respiratory Syncytial Virus Infections / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D012136:Respiratory Syncytial Viruses; D012254:Ribavirin / Q000627:therapeutic use*; D012307:Risk Factors; D014765:Viral Vaccines
D000998:Antiviral Agents; D014765:Viral Vaccines; D012254:Ribavirin